A new policy that recommends offering hepatitis B vaccine at birth only to babies perceived to be at risk will lead to ...

The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the weedkiller ...

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...

Kennedy broke his pledge to share a controversial contract, highlighting Democrats' frustrations with the health secretary.

The Trump administration underlines a “clear shift away from harm reduction and practices” that it says facilitates illegal ...

Archelle Georgiou understands Americans’ frustrations with prior authorization. She helped squash the practice before, at ...

Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news ...

Intellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with ...

“Think of it like charging your phone,” Motif co-founder and CEO Jacob Robinson told STAT’s O. Rose Broderick. Read their ...

A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical ...

The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.

FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...